توقعات سوق المستحضرات الصيدلانية الإشعاعية في الشرق الأوسط وأفريقيا حتى عام 2028 - تأثير كوفيد-19 والتحليل الإقليمي حسب النوع (الطب النووي التشخيصي والطب النووي العلاجي)، والتطبيق (علم الأورام، وأمراض القلب، وأمراض الأعصاب، وغيرها)، والمستخدم النهائي (المستشفيات ومراكز التصوير، المراكز الأكاديمية والبحثية وغيرها)

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        MEA Radiopharmaceuticals Market – By Type

1.3.2        MEA Radiopharmaceuticals Market – By Application

1.3.3        MEA Radiopharmaceuticals Market – By End User

1.3.4        MEA Radiopharmaceuticals Market– By Country

2.           Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           MEA Radiopharmaceuticals Market– Market Landscape

4.1         Overview

4.2         MEA PEST Analysis

4.3         Experts Opinion

5.           MEA Radiopharmaceuticals Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Escalation in the Usage of Alpha Radio Immunotherapy

5.1.2        Surging Advancements in Nuclear Imaging Techniques

5.2         Market Restraints

5.2.1        Accessibility of Substitutes

5.3         Market Opportunities

5.3.1        Growth Potential in Several Countries

5.4         Future Trends

5.4.1        Burgeoning Usage of Nuclear Medicines for Personalized Treatment

5.5         Impact Analysis

6.           Radiopharmaceuticals Market– MEA Analysis

6.1         MEA Radiopharmaceuticals Market Revenue Forecast and Analysis

7.           MEA Radiopharmaceuticals Market Analysis – By Type

7.1         Overview

7.2         MEA Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)

7.3         Diagnostic Nuclear Medicine

7.3.1        Overview

7.3.2        Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3        SPECT

7.3.3.1          Overview

7.3.3.2          SPECT: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4        PET

7.3.4.1          Overview

7.3.4.2          PET: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Therapeutic Nuclear Medicine

7.4.1        Overview

7.4.2        Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3        Alpha Emitters

7.4.3.1          Overview

7.4.3.2          Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4        Beta Emitters

7.4.4.1          Overview

7.4.4.2          Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.5        Brachytherapy Isotopes

7.4.5.1          Overview

7.4.5.2          Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.           MEA Radiopharmaceuticals Market Analysis – By Application

8.1         Overview

8.2         MEA Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)

8.3         Oncology

8.3.1        Overview

8.3.2        Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Cardiology

8.4.1        Overview

8.4.2        Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Neurology

8.5.1        Overview

8.5.2        Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Others

8.6.1        Overview

8.6.2        Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.           MEA Radiopharmaceuticals Market Analysis – By End User

9.1         Overview

9.2         MEA Radiopharmaceuticals Market Share, by End User, 2021 and 2028, (%)

9.3         Hospitals

9.3.1        Overview

9.3.2        Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Imaging Centres

9.4.1        Overview

9.4.2        Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Academic and Research Centers

9.5.1        Overview

9.5.2        Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.6         Others

9.6.1        Overview

9.6.2        Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

10.        MEA Radiopharmaceuticals Market – Country Analysis

10.1      MEA: Radiopharmaceuticals Market

10.1.1     Overview

10.1.2     MEA: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)

10.1.2.1       Saudi Arabia: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.1       Saudi Arabia: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.2       Saudi Arabia Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2.1     Saudi Arabia: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.1.2.2     Saudi Arabia: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.1.3       Saudi Arabia Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

10.1.2.1.4       Saudi Arabia Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

10.1.2.2       UAE: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.1       UAE: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.2       UAE Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2.1     UAE: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.2.2.2     UAE a: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.2.3       UAE Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

10.1.2.2.4       UAE Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.2.3       South Africa: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.1       South Africa: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.2       South Africa Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2.1     South Africa: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.3.2.2     South Africa: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.3.3       South Africa Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

10.1.2.3.4       South Africa Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.2.4       Rest of MEA: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.1       Rest of MEA: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.2       Rest of MEA Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.4.2.1     Rest of MEA: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.4.2.2     Rest of MEA: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.4.3       Rest of MEA Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

10.1.2.4.4       Rest of MEA Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

11.        Impact Of COVID-19 Pandemic on MEA Radiopharmaceuticals Market

11.1      MEA: Impact Assessment of COVID-19 Pandemic

12.        Industry Landscape

12.1      Overview

12.2      Inorganic Growth Strategies

12.2.1     Overview

12.3      Organic Growth Strategies

12.3.1     Overview

13.        Company Profiles

13.1      Cardinal Health Inc

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Curium

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      GENERAL ELECTRIC

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Bayer AG

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Bracco Imaging S.p.A

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      ECZACIBA?I MONROL NUCLEAR PRODUCTS CO.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Nordion

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      NTP RADIOISOTOPES

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      Advanced Accelerator Applications

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

Table 1.             MEA Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Table 2.             Saudi Arabia Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 3.             Saudi Arabia Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 4.             Saudi Arabia Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 5.             Saudi Arabia Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 6.             Saudi Arabia Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 7.             UAE Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 8.             UAE Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 9.             UAE Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 10.          UAE Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 11.          UAE Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 12.          South Africa Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 13.          South Africa Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 14.          South Africa Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 15.          South Africa Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 16.          South Africa Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 17.          Rest of MEA Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 18.          Rest of MEA Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 19.          Rest of MEA Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 20.          Rest of MEA Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 21.          Rest of MEA Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 22.          Recent Inorganic Growth Strategies

Table 23.          Recent Organic Growth Strategies

Table 24.          Glossary of Terms

Figure 1.           MEA Radiopharmaceuticals Market Segmentation

Figure 2.           MEA Radiopharmaceuticals Market Segmentation, By Country

Figure 3.           MEA Radiopharmaceuticals Market Overview

Figure 4.           Diagnostic Nuclear Medicine Segment Held the Largest Share of the Market in 2021

Figure 5.           Saudi Arabia to Show Significant Growth During Forecast Period

Figure 6.           MEA PEST Analysis

Figure 7.           MEA Radiopharmaceuticals Market Impact Analysis of Drivers and Restraints

Figure 8.           MEA Radiopharmaceuticals Market– Revenue Forecast and Analysis

Figure 9.           MEA Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)

Figure 10.        MEA Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.        MEA SPECT: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        MEA PET: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        MEA Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        MEA Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        MEA Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        MEA Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        MEA Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)

Figure 18.        MEA Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        MEA Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        MEA Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        MEA Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        MEA Radiopharmaceuticals Market Share, by End User, 2021 and 2028 (%)

Figure 23.        MEA Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        MEA Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        MEA Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        MEA Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        MEA: Radiopharmaceuticals Market, by Key Country – Revenue (2021) (USD Million)

Figure 28.        MEA: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)

Figure 29.        Saudi Arabia: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

Figure 30.        UAE: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

Figure 31.        South Africa: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

Figure 32.        Rest of MEA: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

Figure 33.        Impact of COVID-19 Pandemic in MEA Country Markets

1. Advanced Accelerator Applications
2. Bayer AG
3. Bracco Imaging S.p.A
4. Cardinal Health Inc
5. Curium
6. ECZACIBA?I MONROL NUCLEAR PRODUCTS CO.
7. GENERAL ELECTRIC
8. Nordion
9. NTP RADIOISOTOPES     

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the MEA radiopharmaceuticals market.           
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the MEA radiopharmaceuticals market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the radiopharmaceuticals market, as well as those hindering it 
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution